Patient-Reported Physical Functioning May Predict HCT Outcomes
the ONA take:
Patient-reported outcomes have the potential to improve prognostication in patients undergoing hematopoietic stem cell transplantation (HSCT), a new study published online ahead of print in the journal Cancer has shown.
Although patient-reported outcomes predict mortality in multiple cancers, there are few studies assessing their value in HSCT.
Therefore, researchers sought to determine whether pre-HSCT patient-reported outcomes, particularly physical health, predict survival among patients undergoing autologous or allogeneic HSCT.
For the analysis, the researchers analyzed data from pre-HSCT patient-reported outcomes that were reported by 336 allogeneic and 310 autolgous HSCT recipients. Participants were enrolled in a larger study that included a broad representation of patients who underwent HSCT in the United States.
Results showed that physical functioning independently predicted overall mortality among allogeneic HSCT recipients. Researchers found that early post-HSCT declines in physical functioning were associated with higher overall and treatment-related mortality.
The authors recommend that patient-reported outcomes be routinely collected prior to HSCT, and that patient-reported outcomes be considered for incorporation into risk adjustment for quality reporting.
Patient-reported outcomes have the potential to improve prognostication in patients undergoing hematopoietic stem cell transplantation.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Open Hysterectomy Survival Rates Edge Minimally Invasive Procedures for Cervical Cancer
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|